Cargando…

The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation

Detalles Bibliográficos
Autores principales:	Harrod, Robert, Romeo, Megan, Malu, Aditi, Hutchison, Tetiana, White, Averi, Gardner, Rachel, Nguyen, Olivia, Hazen, Catherine, Rao, Neha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577817/ http://dx.doi.org/10.1186/1742-4690-12-S1-P10

Ejemplares similares

Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors
por: Harrod, Robert
Publicado: (2019)

HCV and Lymphoproliferation
por: Zignego, Anna Linda, et al.
Publicado: (2012)

The Botanical Glycoside Oleandrin Inhibits Human T-cell Leukemia Virus Type-1 Infectivity and Env-Dependent Virological Synapse Formation
por: Hutchison, Tetiana, et al.
Publicado: (2019)

Regulation of Expression and Latency in BLV and HTLV
por: Pluta, Aneta, et al.
Publicado: (2020)

p30 protein: a critical regulator of HTLV-1 viral latency and host immunity
por: Moles, Ramona, et al.
Publicado: (2019)

Clonality, latency and integration of HTLV-1 in vivo
por: Bangham, Charles, et al.
Publicado: (2013)

Lymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations
por: S, Eldershaw, et al.
Publicado: (2021)

Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
por: Prka, Zeljko, et al.
Publicado: (2012)

Latency Reversing Agents: Kick and Kill of HTLV-1?
por: Schnell, Annika P., et al.
Publicado: (2021)

The Exceptional Oncogenicity of HTLV-1
por: Tagaya, Yutaka, et al.
Publicado: (2017)

Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients
por: Wobser, Marion, et al.
Publicado: (2021)

Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice
Publicado: (1993)

Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation
por: Quartuccio, Luca, et al.
Publicado: (2009)

The tumor microenvironment may trigger lymphoproliferation in cardiac myxoma
por: Jantuan, Eugeniu, et al.
Publicado: (2020)

Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation
por: Li, Guomin, et al.
Publicado: (2020)

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma
por: Ramos, Juan C, et al.
Publicado: (2011)

HTLV-1: Regulating the Balance Between Proviral Latency and Reactivation
por: Kulkarni, Anurag, et al.
Publicado: (2018)

HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties
por: Ciminale, Vincenzo, et al.
Publicado: (2014)

Detection of EBV in reactive and neoplastic lymphoproliferations in adults—when and how?
por: Stuhlmann-Laeisz, Christiane, et al.
Publicado: (2014)

PB2166: TET ENZYMES PROTECT AGAINST FATAL LYMPHOPROLIFERATION
por: Spoeck, S., et al.
Publicado: (2022)

Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2
por: Rende, Francesca, et al.
Publicado: (2012)

Aberrant Expression of the p53 Tumor Suppressor Gene in Adult T‐Cell Leukemia and HTLV‐I‐infected Cells
por: Yamato, Kenji, et al.
Publicado: (1993)

AHR is a tunable knob that controls HTLV-1 latency-reactivation switching
por: Hong, Weihao, et al.
Publicado: (2020)

Epstein-Barr Virus Related Lymphoproliferations After Stem Cell Transplantation
por: Sica, Simona, et al.
Publicado: (2009)

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations
por: Fox, Christopher P, et al.
Publicado: (2011)

Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation
por: Soares, Andreia, et al.
Publicado: (2010)

Defining Immune Engagement Thresholds for In Vivo Control of Virus-Driven Lymphoproliferation
por: Godinho-Silva, Cristina, et al.
Publicado: (2014)

Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
por: Wegehaupt, Oliver, et al.
Publicado: (2020)

P1297: ABERRANT MYCN EXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA
por: Vanden Bempt, M., et al.
Publicado: (2022)

Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity
por: Goudy, Kevin, et al.
Publicado: (2013)

EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts
por: Dojcinov, Stefan D., et al.
Publicado: (2018)

NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation
por: Boztug, Heidrun, et al.
Publicado: (2016)

Probiotic bacteria prevent Salmonella – induced suppression of lymphoproliferation in mice by an immunomodulatory mechanism
por: Wagner, R. Doug, et al.
Publicado: (2017)

Clonal T‐cell Lymphoproliferation Containing Epstein‐Barr (EB) Virus DNA in a Patient with Chronic Active EB Virus Infection
por: Ishihara, Shigehiko, et al.
Publicado: (1989)

Entry of Polarized Effector Cells into Quiescence Forces HIV Latency
por: Dobrowolski, Curtis, et al.
Publicado: (2019)

Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I
Publicado: (1995)

Lymphoproliferation Impairment and Oxidative Stress in Blood Cells from Early Parkinson’s Disease Patients
por: Vida, Carmen, et al.
Publicado: (2019)

Rationally repurposed nitroxoline inhibits preclinical models of Epstein–Barr virus-associated lymphoproliferation
por: Ibáñez de Garayo, Maite, et al.
Publicado: (2021)

Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know
por: Sharma, Saniya, et al.
Publicado: (2022)

An Unusual Case of Recurrent Gingival Epstein-Barr Virus-Positive B-Cell Lymphoproliferation
por: Le Gatt, Pauline, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fjcpr8qqt13oa3ka2teu2d7h5o